some positive signs emerging
FY23 sales order target of A$36M exceeded; Q3 FY23 sales orders of A$11.3M (TCV1) up 156% on A$4.4M in Q3 FY22, bringing year to date sales orders to A$37.1M
Contracted Annual Recurring Revenue (CARR) of A$20.6M; (A$20.0M at 31 Dec 2022)
Annual Recurring Revenue (ARR) run rate of A$17.2M; (A$16.4M at 31 Dec 2022)
Adventist Health System final sales orders received and deployment phase commenced
Cash on hand A$19.4M; (A$20.6M at 31 Dec 2022 )
some positive signs emerging FY23 sales order target of A$36M...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
-0.010(2.56%) |
Mkt cap ! $89.28M | |||
| Open | High | Low | Value | Volume |
| 38.5¢ | 39.0¢ | 36.5¢ | $127.0K | 336.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 11082 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 1637 | 1 |
View Market Depth
| Last trade - 16.10pm 31/07/2025 (20 minute delay) ? |
| M7T (ASX) Chart |